User profiles for C. Simone
Charles B. Simone, IINew York Proton Center; Memorial Sloan Kettering Cancer Center Verified email at nyproton.com Cited by 19170 |
[HTML][HTML] Physical and functional HAT/HDAC interplay regulates protein acetylation balance
A Peserico, C Simone - Biomed Research International, 2011 - hindawi.com
… Based on these data, we have previously proposed an experimental model in which a
deacetylase activity is recruited by the C/H3 region of p300 antagonizing p300 functionality [19]. …
deacetylase activity is recruited by the C/H3 region of p300 antagonizing p300 functionality [19]. …
Management of stage III non–small-cell lung cancer: ASCO guideline
…, A Qin, C Robinson, CB Simone - Journal of Clinical …, 2022 - ingentaconnect.com
PURPOSE To provide evidence-based recommendations to practicing clinicians on
management of patients with stage III non–small-cell lung cancer (NSCLC). METHODS An Expert …
management of patients with stage III non–small-cell lung cancer (NSCLC). METHODS An Expert …
[PDF][PDF] Antioxidants and other nutrients do not interfere with chemotherapy or radiation therapy and can increase kill and increase survival, Part 2
CB Simone II, NL Simone, V Simone… - … therapies in health …, 2007 - naturopath4you.com
… Simone, MD, is a consulting physician and medical director, all at the Simone Protective …
Phase I study of mitomycin C and menadione in advanced solid tumors. Cancer Chemother …
Phase I study of mitomycin C and menadione in advanced solid tumors. Cancer Chemother …
Use of proteomic patterns in serum to identify ovarian cancer
Background New technologies for the detection of early-stage ovarian cancer are urgently
needed. Pathological changes within an organ might be reflected in proteomic patterns in …
needed. Pathological changes within an organ might be reflected in proteomic patterns in …
Serum proteomic patterns for detection of prostate cancer
…, L Wiegand, K Wood, CB Simone… - Journal of the …, 2002 - academic.oup.com
Pathologic states within the prostate may be reflected by changes in serum proteomic patterns.
To test this hypothesis, we analyzed serum proteomic mass spectra with a bioinformatics …
To test this hypothesis, we analyzed serum proteomic mass spectra with a bioinformatics …
Force modeling for needle insertion into soft tissue
AM Okamura, C Simone… - IEEE transactions on …, 2004 - ieeexplore.ieee.org
… Phase (c) represents the period between the time when the liver stops … (c), the tissue is no
longer moving, resulting in a relative velocity equaling that of only the needle, so that phase (c) …
longer moving, resulting in a relative velocity equaling that of only the needle, so that phase (c) …
p38 pathway targets SWI-SNF chromatin-remodeling complex to muscle-specific loci
C Simone, SV Forcales, DA Hill, AN Imbalzano… - Nature …, 2004 - nature.com
… (c) MyoD-associated acetyltransferase activity was … activity was evaluated by C 14 incorporation
(middle panel) of free … incorporation of C 14 acetylated coenzyme A relative to the C 14 …
(middle panel) of free … incorporation of C 14 acetylated coenzyme A relative to the C 14 …
Proton FLASH radiotherapy for the treatment of symptomatic bone metastases: the FAST-01 nonrandomized trial
…, RA Sharma, D Khuntia, JD Bradley, CB Simone… - JAMA …, 2023 - jamanetwork.com
Importance To our knowledge, there have been no clinical trials of ultra-high-dose-rate
radiotherapy delivered at more than 40 Gy/sec, known as FLASH therapy, nor first-in-human use …
radiotherapy delivered at more than 40 Gy/sec, known as FLASH therapy, nor first-in-human use …
[HTML][HTML] Deacetylase inhibitors increase muscle cell size by promoting myoblast recruitment and fusion through induction of follistatin
S Iezzi, M Di Padova, C Serra, G Caretti, C Simone… - Developmental cell, 2004 - cell.com
Fusion of undifferentiated myoblasts into multinucleated myotubes is a prerequisite for
developmental myogenesis and postnatal muscle growth. We report that deacetylase inhibitors …
developmental myogenesis and postnatal muscle growth. We report that deacetylase inhibitors …
[HTML][HTML] A systematic review of the cost and cost-effectiveness studies of immune checkpoint inhibitors
Background Escalating healthcare costs are necessitating the practice of value-based
oncology. It is crucial to critically evaluate the economic impact of influential but expensive …
oncology. It is crucial to critically evaluate the economic impact of influential but expensive …